Reiners Christoph, Schneider Peter
Clinic and Policlinic for Nuclear Medicine, University of Würzburg, Josef-Schneider-Strasse 2, 97080 Würzburg, Germany.
Eur J Nucl Med Mol Imaging. 2002 Aug;29 Suppl 2:S471-8. doi: 10.1007/s00259-002-0910-6. Epub 2002 Jul 18.
Over half a century, treatment of thyroid autonomy with an oral dose of iodine-131 has proven to be effective. The optimum management strategy for the patient is, however, still a matter of debate. The article provides an overview of the pathogenesis of functional autonomy and its clinical relevance. According to the guidelines on both sides of the Atlantic, radioiodine treatment is considered the most comfortable and economical approach to the treatment of the toxic nodular goitre. Some differences in the preparation procedures in the guidelines of the American and the German Society of Nuclear Medicine are discussed with respect to therapy results and the subtypes of thyroid autonomy. The results of studies are summarised concerning changes in thyroid function and thyroid volume after a course of radioiodine treatment. Therapy-related risks, such as immunogenic hypothyroidism or thyroid cancer, are discussed. (131)I treatment of functional autonomy and hyperthyroidism is considered an effective and safe procedure.
半个多世纪以来,口服碘 - 131治疗甲状腺自主性已被证明是有效的。然而,对患者而言,最佳的管理策略仍存在争议。本文概述了功能性自主性的发病机制及其临床意义。根据大西洋两岸的指南,放射性碘治疗被认为是治疗毒性结节性甲状腺肿最舒适且经济的方法。就治疗效果和甲状腺自主性的亚型而言,讨论了美国和德国核医学协会指南中准备程序的一些差异。总结了放射性碘治疗疗程后甲状腺功能和甲状腺体积变化的研究结果。还讨论了与治疗相关的风险,如免疫性甲状腺功能减退或甲状腺癌。碘 - 131治疗功能性自主性和甲状腺功能亢进被认为是一种有效且安全的方法。